Stephana Eilene Patton
CIK 1698237 · Chief Legal Officer · last filed 2025-02-21
Stephana Eilene Patton is a Chief Legal Officer who has filed 14 SEC Form 4 insider transactions across 3 companies since 2017. The most recent filing shows the insider had shares withheld for taxes covering $261 of CUTR on Feb 21, 2025. Across all open-market trades the lifetime net is +$30.4K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
14
$30.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CUTERA INC (CUTR) Delisted | Chief Legal Officer | 77,216 | $0.10 | $7.5K | $0 | 6 | 2025-02-21 |
| Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | See Remarks | 17,948 | $1.73 | $31.0K | $11.0K | 4 | 2021-03-15 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | General Counsel & Secretary | 7,500 | — | — | $19.4K | 2 | 2018-03-19 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-21 | CUTERA INC (CUTR) Delisted | Tax (F) | −623 | -$261 | EDGAR |
| 2024-11-15 | CUTERA INC (CUTR) Delisted | Tax (F) | −2,161 | -$767 | EDGAR |
| 2024-11-05 | CUTERA INC (CUTR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-07-17 | CUTERA INC (CUTR) Delisted | Mixed | — | $0 | EDGAR |
| 2024-05-14 | CUTERA INC (CUTR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-08 | CUTERA INC (CUTR) Delisted | Grant (A) | +80,000 | $0 | EDGAR |
| 2021-03-15 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | +11,875 | $0 | EDGAR |
| 2020-03-13 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | +820 | $6.0K | EDGAR |
| 2019-04-22 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Buy (P) | +1,000 | $11.0K | EDGAR |
| 2019-03-25 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | — | $0 | EDGAR |